Starting 2024 with an outlook on our goals 🎯
👨👩👧👦 Further build R&D organization hiring additional internal HR resources
💡 Further build preclinical models and extend research activities regarding Mechanism of Action
🚑 Continue to gain insights from clinical and translational advisory committees
✒ Execute EMA/FDA scientific advice meetings
👩🔬 Preparation and initiation of Phase 2b study
🏥 Restart production of the clinical investigational medicinal product with improved manufacturing method with established partners
🏅 Optimise quality, standardisation and characterisation of VCC-001 in collaboration with external partners
⚽ Initiate pharma economic research for value dossier and cost-benefit calculation
